Consolidated Statements of Operations (USD $)	12 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
Revenue	$ 5,931	$ 11,862
Operating expenses:
General and administrative (including stock-based compensation (Note 8))	2,269,045	6,874,573
Depreciation	978,798	905,871
Impairment loss on property and equipment (Note 3)	2,000,000
Research and development (including stock-based compensation (Note 8))	134,862	191,709
Total operating expenses	5,382,705	7,972,153
Loss from operations	(5,376,774)	(7,960,291)
Other expense:
Interest expense	403,410	289,604
Gain on extinguishment of liabilities (Note 9)	(20,113)
Other expense	1,918
	385,215	289,604
Net loss	(5,761,989)	(8,249,895)
Net loss attributable to the noncontrolling interest	2,976	6,134
Net loss attributable to Bion	(5,759,013)	(8,243,761)
Dividends on preferred stock	(2,000)	(4,417)
Net loss applicable to Bion's common stockholders	$ (5,761,013)	$ (8,248,178)
Net loss applicable to Bion's common stockholders per basic and diluted common share (in Dollars per share)	$ (0.31)	$ (0.48)
Weighted-average number of common shares outstanding:
Basic and diluted (in Shares)	18,636,364	17,315,436